Baxter boosts profits by 7.5%; Novartis sues Sun to block Zometa copies;

 @FiercePharma: PDI expects $57M from deal to market 'newly FDA approved drug'. ‪Vivus‬ diet pill Qsymia, maybe? Release | Follow @FiercePharma

> Baxter International ($BAX) posted a 7.5% increase in second-quarter profits, as sales grew slightly to $3.6 billion. Report

> Novartis sued Sun Pharmaceutical Industries to block the Indian genericsmaker's version of the osteoporosis drugs Zometa and Reclast, which together brought in more than $2 billion in 2011 sales. News

> Under a federal judge's ruling, Johnson & Johnson ($JNJ) won't have to fight consumer claims stemming from the quality problems and recalls within its consumer drug division. Report

> Baxter International won FDA approval for a new dosage strength of its hemophilia drug Advate. Report

> Actelion managed to post a profit for the first half of this year, thanks to cost-cutting efforts that outweighed a decline in Tracleer sales. Report

> SkyePharma invested £5 million ($7.8 million) to help build a facilty for the manufacture of Sanofi's Flutiform. Report

> Somaxon settled another patent fight over its sleep drug Silenor, this time with Cadila Healthcare and Zydus Pharma. Release

Biotech News

 @FierceBiotech: Study: Low-income patients less likely to join cancer‬ trials. Report | Follow @FierceBiotech

 @JohnCFierce: Interesting approach--super high risk; EnVivo grabs ‪Alzheimer‬'s spotlight with promising PhIIb results. News | Follow @JohnCFierce

 @RyanMFierce: Innovation in ‪pharma‬ manufacturing is under-appreciated. Thinking about this as I cover Novartis' woes at Lincoln, NE plant. Hurt Q2 sales.  | Follow @RyanMFierce

> Faded star at Pfizer leads to discounted $68M IPO for Durata. Article

> Infinity restructures drug deal, raises $27.5M as it scrambles to refocus. News

> Multibillion-dollar R&D strategy is paying off for Novartis. More

Medical Device News

@FierceMedDev: Medtronic appears to be negotiating with Indian device giant Trivitron Healthcare for a "strategic investment." More | Follow @FierceMedDev

 @MarkHFierce: U.K. Sanofi site draws $7.8M investment for asthma inhaler production. Item | Follow @MarkHFierce

 @DamianFierce: Quest Dx and LabCorp are scaling back expectations after a tepid Q2. More | Follow @DamianFierce

> Slow market stunts growth of Quest, LabCorp. Report

> Medtronic reportedly eyes stake in India's Trivitron Healthcare. News

> Weaker euro batters Stryker's Q2 earnings. Article

Pharma Manufacturing News

> Novartis's Q2 sales hit after Excedrin production woes. News

> Sanofi plant adds 40 to produce SkyePharma product. More

> Docs reportedly get smuggled cancer drugs in Pakistan bazaar. Story

> J&J 'decree' upgrades cost 200 jobs in Puerto Rico. Article

CRO News

> Medpace adds clinical pharma unit for PhI trials. Story

> ScinoPharm will manufacture blockbuster hopeful Qsymia. Article

> Europe moves toward liberalizing clinical trial rules. More

> Study: Low-income patients less likely to join cancer trials. Report

> Indian regulators shutter 12 drug plants over enviro concerns. News

Vaccines News

> Galena stock jumps with NeuVax patent. Report

> Oral vax rides on advanced microparticles. News

> Silk could eliminate 'cold chain' need. Story

> MedImmune to cut 200 jobs, layoffs hit vax R&D. Article

> University of Birmingham explores attitudes toward polio vax in India. More

> HIV-positive patients approved for smallpox vax in an emergency. Item

And Finally... Sitting around all day isn't just making you unhealthy. It might also be making you dumber. Report